Literature DB >> 11114275

Validated measurement of periarticular bone mineral density at the knee joint by dual energy x ray absorptiometry.

E Murphy1, B Bresnihan, O FitzGerald.   

Abstract

OBJECTIVE: The association of inflammatory arthritis with loss of periarticular bone mineral density (BMD) has been well established. However, changes in bone density cannot be quantified by conventional radiography. This study aimed at developing a new technique for measurement of periarticular bone density at the knee joint by dual energy x ray absorptiometry (DXA) and assessing the precision of this technique for selected areas around the knee.
METHODS: To validate this technique for bone density assessment in both patient and control subjects, knee joints from healthy subjects and patients with inflammatory arthritis were selected for study. Posteroanterior (PA) and lateral scans of both knees were acquired with the Hologic 4500 elite bone densitometer. Each scan was repeated three times, with repositioning between scans. Knee scans were obtained with the forearm software and evaluated by subregion analysis. Seven femoral and seven tibial subregions of interest (ROIs) were selected on PA scans. Six ROIs were selected on lateral scans. Precision was determined for each ROI selected.
RESULTS: 14 knee joints were studied in each group. Precision, expressed as percentage coefficient of variation (CV%), varied widely between subregions. PA scans were most appropriate for measurement of femoral bone density (CV% = 1.89-2.64%), whereas the best value obtained for ROIs within the tibia was on the lateral scan, where CV% for measurement of the proximal 5 mm was 2.67% in the patient group. CV% for BMD of the patella was excellent at 0.84% in the patient group.
CONCLUSION: This new application of DXA can be used to measure periarticular bone density at the knee joint. Regions within the distal femur and patella have been identified as the optimal areas to study

Entities:  

Mesh:

Year:  2001        PMID: 11114275      PMCID: PMC1753370          DOI: 10.1136/ard.60.1.8

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

Review 1.  Bone mass in patients with rheumatoid arthritis.

Authors:  R F Laan; P L van Riel; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Appropriate use of bone densitometry.

Authors:  H K Genant; J E Block; P Steiger; C C Glueer; B Ettinger; S T Harris
Journal:  Radiology       Date:  1989-03       Impact factor: 11.105

3.  Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques.

Authors:  C C Glüer; G Blake; Y Lu; B A Blunt; M Jergas; H K Genant
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

4.  Generalised bone loss in patients with early rheumatoid arthritis.

Authors:  A K Gough; J Lilley; S Eyre; R L Holder; P Emery
Journal:  Lancet       Date:  1994-07-02       Impact factor: 79.321

5.  Measurement of hand bone mineral content using single-photon absorptiometry.

Authors:  J J Nicoll; M A Smith; D Reid; E Law; N Brown; P Tothill; G Nuki
Journal:  Phys Med Biol       Date:  1987-06       Impact factor: 3.609

6.  Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids.

Authors:  A Verstraeten; J Dequeker
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

7.  Total and peripheral bone mass in patients with psoriatic arthritis and rheumatoid arthritis.

Authors:  D M Reid; N S Kennedy; J Nicoll; M A Smith; P Tothill; G Nuki
Journal:  Clin Rheumatol       Date:  1986-09       Impact factor: 2.980

8.  Measurement of hand bone mineral content by dual energy x-ray absorptiometry: development of the method, and its application in normal volunteers and in patients with rheumatoid arthritis.

Authors:  A A Deodhar; J Brabyn; P W Jones; M J Davis; A D Woolf
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

9.  Bone turnover in early rheumatoid arthritis. 2. Longitudinal bone density studies.

Authors:  P N Sambrook; B M Ansell; S Foster; J M Gumpel; R Hesp; J Reeve
Journal:  Ann Rheum Dis       Date:  1985-09       Impact factor: 19.103

10.  In vivo analysis of bone calcium by local neutron activation of the hand: results in normal and osteoporotic subjects.

Authors:  B Maziere; D Kuntz; D Comar; A Ryckewaert
Journal:  J Nucl Med       Date:  1979-02       Impact factor: 10.057

View more
  5 in total

1.  Comparison of volumetric bone mineral density in the tibial region of interest for ACL reconstruction.

Authors:  Scott A Klein; John Nyland; David N M Caborn; Yavuz Kocabey; Akbar Nawab
Journal:  Surg Radiol Anat       Date:  2005-10-20       Impact factor: 1.246

Review 2.  Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options.

Authors:  C M Cirnigliaro; M J Myslinski; M F La Fountaine; S C Kirshblum; G F Forrest; W A Bauman
Journal:  Osteoporos Int       Date:  2016-12-05       Impact factor: 4.507

3.  Bone mineral density after spinal cord injury: a reliable method for knee measurement.

Authors:  Richard K Shields; Janet Schlechte; Shauna Dudley-Javoroski; Bradley D Zwart; Steven D Clark; Susan A Grant; Vicki M Mattiace
Journal:  Arch Phys Med Rehabil       Date:  2005-10       Impact factor: 3.966

4.  Increased serum cartilage oligomeric matrix protein levels and decreased patellar bone mineral density in patients with chondromalacia patellae.

Authors:  E Murphy; O FitzGerald; T Saxne; B Bresnihan
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

5.  Dual-energy X-ray absorptiometry applied to the assessment of tibial subchondral bone mineral density in osteoarthritis of the knee.

Authors:  S Clarke; C Wakeley; J Duddy; M Sharif; I Watt; K Ellingham; C J Elson; G Nickols; J R Kirwan
Journal:  Skeletal Radiol       Date:  2004-06-24       Impact factor: 2.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.